Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocardial Infarction | 21 | 2022 | 924 | 4.450 |
Why?
|
| Multiple Chronic Conditions | 6 | 2023 | 39 | 3.580 |
Why?
|
| Heart Failure | 12 | 2023 | 942 | 2.800 |
Why?
|
| Multimorbidity | 8 | 2025 | 50 | 1.620 |
Why?
|
| Patient Readmission | 7 | 2021 | 446 | 1.510 |
Why?
|
| Atrial Fibrillation | 10 | 2025 | 873 | 1.410 |
Why?
|
| Acute Coronary Syndrome | 4 | 2017 | 254 | 1.360 |
Why?
|
| Hospitalization | 13 | 2022 | 1391 | 1.330 |
Why?
|
| Chronic Disease | 6 | 2025 | 757 | 1.130 |
Why?
|
| Aged | 36 | 2025 | 14963 | 0.950 |
Why?
|
| Inpatients | 3 | 2019 | 311 | 0.950 |
Why?
|
| Survivors | 2 | 2017 | 184 | 0.920 |
Why?
|
| Diabetes Mellitus | 3 | 2022 | 555 | 0.870 |
Why?
|
| Angiotensin Receptor Antagonists | 4 | 2022 | 65 | 0.830 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 4 | 2022 | 143 | 0.810 |
Why?
|
| Hospital Mortality | 8 | 2018 | 879 | 0.770 |
Why?
|
| Massachusetts | 17 | 2025 | 2149 | 0.760 |
Why?
|
| Aged, 80 and over | 18 | 2025 | 5620 | 0.760 |
Why?
|
| Hyperkalemia | 1 | 2022 | 20 | 0.750 |
Why?
|
| Male | 41 | 2025 | 31082 | 0.740 |
Why?
|
| Age Factors | 9 | 2021 | 1591 | 0.700 |
Why?
|
| Retrospective Studies | 15 | 2023 | 6881 | 0.690 |
Why?
|
| Electrocardiography | 2 | 2015 | 558 | 0.690 |
Why?
|
| Percutaneous Coronary Intervention | 4 | 2022 | 226 | 0.660 |
Why?
|
| Risk Factors | 16 | 2025 | 5445 | 0.660 |
Why?
|
| Female | 40 | 2025 | 34130 | 0.660 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 144 | 0.650 |
Why?
|
| Mobility Limitation | 1 | 2020 | 49 | 0.640 |
Why?
|
| Morbidity | 1 | 2020 | 111 | 0.640 |
Why?
|
| Chest Pain | 2 | 2020 | 85 | 0.620 |
Why?
|
| Humans | 46 | 2025 | 65551 | 0.580 |
Why?
|
| Independent Living | 1 | 2018 | 55 | 0.550 |
Why?
|
| Anemia | 1 | 2019 | 131 | 0.550 |
Why?
|
| Risk Assessment | 7 | 2022 | 2102 | 0.540 |
Why?
|
| Disease Management | 1 | 2019 | 238 | 0.530 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2017 | 152 | 0.520 |
Why?
|
| Length of Stay | 7 | 2017 | 830 | 0.510 |
Why?
|
| Middle Aged | 20 | 2025 | 18281 | 0.500 |
Why?
|
| Time Factors | 10 | 2019 | 3785 | 0.490 |
Why?
|
| Psychosocial Deprivation | 1 | 2015 | 8 | 0.480 |
Why?
|
| Research | 1 | 2017 | 197 | 0.470 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2020 | 493 | 0.460 |
Why?
|
| Survival Rate | 5 | 2019 | 860 | 0.440 |
Why?
|
| Patient Discharge | 6 | 2017 | 521 | 0.430 |
Why?
|
| Cardiac Catheterization | 2 | 2022 | 305 | 0.420 |
Why?
|
| Follow-Up Studies | 6 | 2019 | 2509 | 0.420 |
Why?
|
| Myocardial Revascularization | 1 | 2014 | 78 | 0.400 |
Why?
|
| Quality of Life | 6 | 2022 | 1271 | 0.400 |
Why?
|
| Diabetes Complications | 1 | 2014 | 106 | 0.400 |
Why?
|
| Secondary Prevention | 1 | 2014 | 164 | 0.390 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 438 | 0.390 |
Why?
|
| Forecasting | 1 | 2014 | 232 | 0.390 |
Why?
|
| Comorbidity | 7 | 2025 | 1126 | 0.390 |
Why?
|
| Primary Prevention | 1 | 2014 | 136 | 0.380 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 215 | 0.360 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2014 | 235 | 0.360 |
Why?
|
| Hemorrhage | 2 | 2025 | 280 | 0.360 |
Why?
|
| Multivariate Analysis | 4 | 2017 | 938 | 0.340 |
Why?
|
| Anticoagulants | 3 | 2025 | 520 | 0.330 |
Why?
|
| Sex Factors | 6 | 2020 | 997 | 0.330 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2025 | 151 | 0.320 |
Why?
|
| Anxiety | 2 | 2020 | 438 | 0.310 |
Why?
|
| Stroke | 5 | 2025 | 1216 | 0.310 |
Why?
|
| Frailty | 2 | 2022 | 129 | 0.300 |
Why?
|
| Anxiety Disorders | 1 | 2011 | 202 | 0.290 |
Why?
|
| Treatment Outcome | 8 | 2017 | 5818 | 0.290 |
Why?
|
| Chi-Square Distribution | 4 | 2017 | 416 | 0.290 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 866 | 0.280 |
Why?
|
| Caregivers | 2 | 2025 | 294 | 0.280 |
Why?
|
| United States | 6 | 2025 | 8128 | 0.280 |
Why?
|
| Cause of Death | 2 | 2019 | 223 | 0.270 |
Why?
|
| Depression | 2 | 2020 | 917 | 0.240 |
Why?
|
| Prevalence | 3 | 2025 | 1440 | 0.240 |
Why?
|
| Cohort Studies | 6 | 2025 | 2626 | 0.240 |
Why?
|
| Coronary Artery Bypass | 3 | 2022 | 298 | 0.230 |
Why?
|
| Prognosis | 5 | 2017 | 1795 | 0.210 |
Why?
|
| Cost of Illness | 1 | 2025 | 172 | 0.210 |
Why?
|
| Potassium | 1 | 2022 | 103 | 0.180 |
Why?
|
| Medical Records, Problem-Oriented | 1 | 2021 | 13 | 0.170 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2022 | 63 | 0.170 |
Why?
|
| Colorectal Neoplasms | 1 | 2024 | 281 | 0.170 |
Why?
|
| Parents | 1 | 2025 | 412 | 0.170 |
Why?
|
| Adult | 7 | 2025 | 17408 | 0.160 |
Why?
|
| Early Detection of Cancer | 1 | 2024 | 325 | 0.160 |
Why?
|
| Multiple Myeloma | 1 | 2025 | 366 | 0.160 |
Why?
|
| Needs Assessment | 1 | 2021 | 203 | 0.160 |
Why?
|
| Frail Elderly | 1 | 2020 | 114 | 0.150 |
Why?
|
| Antiviral Agents | 1 | 2022 | 330 | 0.150 |
Why?
|
| Musculoskeletal Diseases | 1 | 2020 | 104 | 0.150 |
Why?
|
| Adaptation, Psychological | 2 | 2012 | 281 | 0.150 |
Why?
|
| Osteoarthritis | 1 | 2020 | 146 | 0.140 |
Why?
|
| Prospective Studies | 4 | 2022 | 3344 | 0.140 |
Why?
|
| Logistic Models | 3 | 2016 | 1279 | 0.130 |
Why?
|
| Incidence | 3 | 2018 | 1413 | 0.130 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 250 | 0.130 |
Why?
|
| Drug Interactions | 1 | 2017 | 127 | 0.130 |
Why?
|
| Surveys and Questionnaires | 3 | 2022 | 2779 | 0.120 |
Why?
|
| Patient Care Management | 1 | 2016 | 30 | 0.120 |
Why?
|
| Patient Outcome Assessment | 1 | 2016 | 57 | 0.120 |
Why?
|
| Health Services Research | 1 | 2017 | 268 | 0.120 |
Why?
|
| Lung Diseases | 1 | 2017 | 183 | 0.120 |
Why?
|
| Georgia | 1 | 2015 | 88 | 0.120 |
Why?
|
| Hypolipidemic Agents | 1 | 2015 | 25 | 0.120 |
Why?
|
| Diuretics | 1 | 2015 | 58 | 0.120 |
Why?
|
| Calcium Channel Blockers | 1 | 2015 | 59 | 0.120 |
Why?
|
| Multicenter Studies as Topic | 1 | 2015 | 155 | 0.110 |
Why?
|
| Self Report | 3 | 2022 | 391 | 0.110 |
Why?
|
| Electronic Health Records | 1 | 2018 | 384 | 0.110 |
Why?
|
| Health Status | 1 | 2017 | 451 | 0.110 |
Why?
|
| Aging | 1 | 2020 | 766 | 0.100 |
Why?
|
| Stroke Volume | 1 | 2015 | 338 | 0.100 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1284 | 0.100 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 313 | 0.100 |
Why?
|
| Personality Inventory | 2 | 2011 | 57 | 0.100 |
Why?
|
| Aspirin | 1 | 2014 | 172 | 0.100 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 1114 | 0.090 |
Why?
|
| Models, Psychological | 1 | 2012 | 102 | 0.090 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 232 | 0.090 |
Why?
|
| Cross-Sectional Studies | 2 | 2025 | 2697 | 0.080 |
Why?
|
| Angina, Unstable | 1 | 2011 | 58 | 0.080 |
Why?
|
| Case-Control Studies | 1 | 2014 | 1157 | 0.080 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2012 | 387 | 0.080 |
Why?
|
| Pediatrics | 1 | 2013 | 266 | 0.080 |
Why?
|
| Fear | 1 | 2011 | 71 | 0.080 |
Why?
|
| Body Mass Index | 1 | 2014 | 888 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 1574 | 0.080 |
Why?
|
| Mental Health Services | 1 | 2013 | 308 | 0.070 |
Why?
|
| Sex Distribution | 2 | 2018 | 250 | 0.070 |
Why?
|
| Age Distribution | 2 | 2018 | 259 | 0.070 |
Why?
|
| Health Services Accessibility | 1 | 2013 | 594 | 0.070 |
Why?
|
| Geriatric Assessment | 2 | 2020 | 161 | 0.060 |
Why?
|
| SEER Program | 1 | 2025 | 75 | 0.060 |
Why?
|
| Glomerular Filtration Rate | 1 | 2025 | 122 | 0.060 |
Why?
|
| Warfarin | 1 | 2025 | 125 | 0.050 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2024 | 45 | 0.050 |
Why?
|
| Health Surveys | 1 | 2025 | 318 | 0.050 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 2002 | 10 | 0.050 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2002 | 19 | 0.050 |
Why?
|
| Fluoxetine | 1 | 2002 | 45 | 0.050 |
Why?
|
| Odds Ratio | 2 | 2015 | 763 | 0.050 |
Why?
|
| Acute Disease | 2 | 2015 | 676 | 0.040 |
Why?
|
| Perception | 1 | 2022 | 183 | 0.040 |
Why?
|
| Antidepressive Agents | 1 | 2002 | 230 | 0.040 |
Why?
|
| Medicare | 1 | 2025 | 617 | 0.040 |
Why?
|
| Depressive Disorder | 1 | 2002 | 288 | 0.040 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2021 | 165 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2020 | 293 | 0.040 |
Why?
|
| Cognition | 1 | 2022 | 502 | 0.030 |
Why?
|
| Patient-Centered Care | 1 | 2020 | 259 | 0.030 |
Why?
|
| Social Support | 1 | 2020 | 388 | 0.030 |
Why?
|
| Urban Health | 1 | 2015 | 40 | 0.030 |
Why?
|
| Cardiotonic Agents | 1 | 2015 | 54 | 0.030 |
Why?
|
| Exercise | 1 | 2022 | 964 | 0.030 |
Why?
|
| Young Adult | 1 | 2025 | 4816 | 0.030 |
Why?
|
| Shock, Cardiogenic | 1 | 2015 | 107 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2013 | 239 | 0.020 |
Why?
|
| Checklist | 1 | 2013 | 72 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 612 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2013 | 590 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 745 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2013 | 312 | 0.020 |
Why?
|
| Edema | 1 | 2010 | 42 | 0.020 |
Why?
|
| Dyspnea | 1 | 2010 | 124 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2010 | 293 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 739 | 0.020 |
Why?
|
| Cough | 1 | 2010 | 184 | 0.020 |
Why?
|
| Adolescent | 2 | 2013 | 6362 | 0.020 |
Why?
|
| Mass Screening | 1 | 2013 | 705 | 0.020 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2010 | 715 | 0.010 |
Why?
|
| Child | 1 | 2013 | 4668 | 0.010 |
Why?
|
| Postmenopause | 1 | 2002 | 239 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2002 | 748 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 880 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2002 | 801 | 0.010 |
Why?
|